UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | P | R | S | T | V | W | Y | Z
Number of items: 223.

A

Aitchison, KL; Rahim, AA; Hughes, DA; Kinnon, C; Waddington, SN; Howe, SJ; (2011) Lentiviral vectors for gene therapy of Type I Gaucher Disease. HUM GENE THER , 22 (10) A44 - A44.

Albanyan, AA; Albanyan, A; Curry, B; Dragovic, R; Gardiner, C; Biggerstaff, J; Murphy, M; (2011) Measurement of procoagulant microvesicles generated within ageing platelet concentrates. In: (pp. pp. 62-63). WILEY-BLACKWELL

Allen, CG; Hills, RK; Evans, CM; Lamb, K; Sellar, R; Moorman, AV; Sale, M; ... Gale, RE; + view all (2011) Mutations in a Large Cohort of Young Adult Patients with Core Binding Factor Acute Myeloid Leukemia: Impact on Outcome and the Selection of Patients for Alternative Treatment Including Transplantation in First Complete Remission. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 193). AMER SOC HEMATOLOGY

Alnabhan, R; Madrigal, JA; Saudemont, A; (2011) Activation of cord blood natural killer cells. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 186). WILEY-BLACKWELL

Alvarez, RA; Thorborn, G; Reading, JL; Reddy, S; Vyakarnam, A; (2011) WFDC1 expression identifies memory CD4 T- lymphocytes rendered vulnerable to cell-cell HIV-1 transfer by promoting intercellular adhesive junctions. Retrovirology , 8 (1) p. 29. 10.1186/1742-4690-8-29.

Ang, JE; Olmos, D; Moreno-Garcia, V; Brunetto, A; Papadatos-Pastos, D; Arkenau, HT; Blanco, M; ... Kaye, SB; + view all (2011) Utility of novel dynamic clinical indices in patients (pts) enrolled in a phase I (Ph I) oncology trial as markers of prognosis and treatment benefit. Journal of Clinical Oncology , 29 (Suppl 1)

Arkenau, H-K; (2011) Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? ANNALS OF ONCOLOGY , 22 (1) 239-U282. 10.1093/annonc/mdq676.

Arrieta Bolanos, ER; Maldonado-Torres, H; Dimitriu, O; Hoddinott, MA; Fowles, F; Shah, A; Órlich-Pérez, P; ... Madrigal, A; + view all (2011) HLA-A, -B, -C, -DQB1, and -DRB1,3,4,5 allele and haplotype frequencies in the Costa Rica Central Valley Population and its relationship to worldwide populations. Human Immunology , 72 (1) pp. 80-86. 10.1016/j.humimm.2010.10.005.

Ayto, RM; Reed, M; Baker, R; Steele, AJ; Wickremasinghe, RG; Mehta, AB; Hughes, DA; (2011) Gaucher derived mono-layers prime myeloma cells for survival against chemo-therapeutic agents. Presented at: 51st Annual Scientific Meeting of the British-Society-for-Haematology, Brighton, ENGLAND.

B

Babu, B; Ramos, J; Liu, Y; Chavda, S; Tzou, S; Brockway, O; Sjoholm, R; ... Lee, M; + view all (2011) Design, synthesis, and DNA binding selectivity and affinity studies of the tetraamide PhIPI and its diamino analog PhIP*I. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Ball, J; Cohen, H; Knowles, S; (2011) A retrospective audit of fluid balance recording in transfusion associated circulatory overload (TACO) reports analysed by the serious hazards of transfusion 9SHOT) scheme. In: (Proceedings) British Blood Transfusion Society.

Ballingall, KT; Herrmann-Hoesing, L; Robinson, J; Marsh, SGE; Stear, MJ; (2011) A single nomenclature and associated database for alleles at the major histocompatibility complex class II DRB1 locus of sheep. TISSUE ANTIGENS , 77 (6) pp. 546-553. 10.1111/j.1399-0039.2011.01637.x.

Baraniskin, A; Munding, J; Schulmann, K; Meier, D; Porschen, R; Arkenau, H-T; Graeven, U; ... Reinacher-Schick, A; + view all (2011) Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group. CLINICAL COLORECTAL CANCER , 10 (1) pp. 24-29. 10.3816/CCC.2011.n.003.

Bates, AW; (2011) The anatomy of beauty in nineteenth-century England. Hektoen International , 3 (1)

Bell, CG; (2011) Accessing and selecting genetic markers from available resources. Methods Mol Biol , 760 pp. 1-17. 10.1007/978-1-61779-176-5_1.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; Buckley, S; ... Nathwani, A; + view all (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45-A45.

Bochtler, W; Maiers, M; Bakker, JNA; Oudshoorn, M; Marsh, SGE; Baier, D; Hurley, CK; (2011) World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant , 46 pp. 338-343.

Bridgewater, JA; Stubbs, C; Primrose, JN; National Cancer Research Institute (UK) Upper Gastrointestinal S, ; (2011) BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer. J Clin Oncol , 29 (15_suppl) 4125-.

Brunetto, A; Olmos, D; Arkenau, H-T; Tan, D; Yap, T; de Bono, J; Barriuso, J; (2011) Perceptions and referral trends into phase I oncology trials: results of a clinical survey. J Oncol , 2011 861401-. 10.1155/2011/861401.

C

Calvert, AH; (2011) Synthetic lethality in cancer treatment: Current status of PARP inhibitors. In: ANNALS OF ONCOLOGY. (pp. 13 - 13). OXFORD UNIV PRESS

Calvert, AH; Jackson, JC; Hutton, C; Swart, AM; Qian, W; Kwakye, C; Fossati, R; ... Lunec, J; + view all (2011) Evaluation of p53 mutation as a predictive biomarker for outcome to chemotherapy in ovarian cancer. J Clin Oncol , 29 (15_suppl) 10522-.

Casper, CJ; Warner, TT; Taanman, JW; Nathwani, AC; (2011) Generation of iPS-derived dopaminergic neurons as an in-vitro model of Rapid-Onset Dystonia Parkinsonism. HUMAN GENE THERAPY , 22 (10) A42 - A43.

Chapman, CE; Stainsby, D; Jones, H; Love, E; Massey, E; Win, N; Navarrete, C; ... Williamson, L; + view all (2011) Erratum: Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma (Transfusion (2009) 49 (440-452)). Transfusion , 51 (12) 2746-. 10.1111/j.1537-2995.2011.03496.x.

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; Westrate, L; ... Lee, M; + view all (2011) Hx, a novel fluorescent, minor groove and sequence specific recognition element: Design, synthesis, and DNA binding properties of p-anisylbenzimidazole imidazole/pyrrole-containing polyamides. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Chew, SK; Rad, R; Futreal, PA; Bradley, A; Liu, P; (2011) Genetic screens using the piggyBac transposon. Methods , 53 (4) pp. 366-371. 10.1016/j.ymeth.2010.12.022.

Chua, MLK; Somaiah, N; Bourne, S; Daley, F; A'Hern, R; Nuta, O; Davies, S; ... Rothkamm, K; + view all (2011) Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin. RADIOTHER ONCOL , 99 (2) 225 - 230. 10.1016/j.radonc.2011.04.009.

Cire, S; Collins, MK; Buchholz, C; Galy, A; (2011) In vivo immunization against male antigens and GFP, with lentiviruses targeted to MHC class II positive cells. HUMAN GENE THERAPY , 22 (10) A69-A69.

Cire, S; Collins, MK; Buchholz, CJ; Galy, A; (2011) An experimental model set-up to study MHC class II targeted gene transfer in antigen-presenting-cells. In: (Proceedings) 10th Annual Congress of the French-Society-of-Cell-and-Gene-Therapy (SFTCG). (pp. A24-A25). MARY ANN LIEBERT INC

Cohen, H; (2011) Current best practice in oral anticoagulation. In: (Proceedings) Sysmex user symposium.

Cohen, H; (2011) Heritable thrombotic risk factors: influence on antiphospholipid syndrome pregnancy outcomes and treatment in pregnancy. Presented at: VIII European Forum on antiphospholipid antibodies, Padua.

Cohen, H; (2011) Heritable thrombotic risk factors: influence on antiphospholipid syndrome pregnancy outcomes and treatment in pregnancy. Presented at: VIII European Forum on antiphospholipid antibodies, Padua.

Cohen, H; (2011) New oral anticoagulants in antiphospholipid syndrome: the RAPS trisl. [Lecture]. Presented at: APS ACTION 2nd annual summit, Chicago.

Cohen, H; (2011) Placental vascular mediated late obstetric morbidity: management and outcomes. [Lecture]. Presented at: British society for haematology obstetric subgroup, Leicester.

Cohen, H; (2011) SHOT 2010 and improving patient safety through interventions based on SHOT data. [Lecture]. Presented at: SHOT annual symposium, London.

Confer, DL; Shaw, BE; Pamphilon, DH; Clinical Working Grp WMDA, ; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. BONE MARROW TRANSPL , 46 (11) 1409 - 1412. 10.1038/bmt.2010.323.

Cox, S.T.; (2011) The relevance and impact of MICA allele mismatching and MICA antibodies on renal transplantation outcome. Doctoral thesis , UCL (University College London). Green open access
file

Cuomo, ME; Platt, GM; Pearl, LH; Mittnacht, S; (2011) Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition. J BIOL CHEM , 286 (11) 9713 - 9725. 10.1074/jbc.M110.173872. Gold open access

D

Dancey, G.S.; (2011) Novel radioimmunotherapy for lymphoma and solid tumours both as a single agent and in combination with the vascular disrupting agents. Doctoral thesis , UCL (University College London). Green open access
file

David, AL; McIntosh, J; Peebles, DM; Cook, T; Waddington, S; Weisz, B; Wigley, V; ... Nathwani, AC; + view all (2011) Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep. HUM GENE THER , 22 (4) 419 - 426. 10.1089/hum.2010.007.

Davies, T; Poles, D; Watt, A; Ball, J; Mistry, H; Knowles, S; Cohen, H; (2011) SHOT participation and benchmarking data 2010. In: (Proceedings) British Blood Transfusion Society.

De, S; Varsally, W; Falciani, F; Brogna, S; (2011) Ribosomal proteins' association with transcription sites peaks at tRNA genes in Schizosaccharomyces pombe. RNA-A PUBLICATION OF THE RNA SOCIETY , 17 (9) pp. 1713-1726. 10.1261/rna.2808411.

Denbo, JW; Williams, RF; Orr, WS; Sims, TL; Ng, CY; Zhou, JF; Spence, Y; ... Davidoff, AM; + view all (2011) Continuous local delivery of interferon-beta stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model. SURGERY , 150 (3) 497 - 504. 10.1016/j.surg.2011.07.044.

Dina, R; Gudi, M; Kocjan, G; Schmitt, F; Vielh, P; (2011) Reply to: The danger to cytopathology of overspecialization and its relevance for histopathology Authors' response. CYTOPATHOLOGY , 22 (3) 209 - 210. 10.1111/j.1365-2303.2011.00875.x.

Donaldson, J; Khan, WS; Tailor, H; Hughes, DA; Mehta, AB; Maruthainar, N; (2011) Gaucher disease: outcome following total hip replacements and effect of enzyme replacement therapy in a cohort of UK patients. HIP INTERNATIONAL , 21 (6) pp. 665-671. 10.5301/HIP.2011.8826.

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 2). WILEY-BLACKWELL

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (pp. p. 2).

Drebes, AB; Khalil, A; O'Brien, P; Cohen, H; (2011) Late obstetric morbidity in women with and without inherited or acquired thrombophilia: management and outcomes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 631.

Dudderidge, J; Vasdev, N; Wollenschlaeger, A; Okoturo, O; Kelly, J; Stoeber, K; (2011) Diagnosis of bladder cancer by combined detection of minichromosome maintenance 5 protein and NMP22 in urine. In: BJU INTERNATIONAL. (pp. 7 - 7). WILEY-BLACKWELL

Dudderidge, TJ; Beatty, J; Larkin, J; Gore, M; Christmas, TJ; (2011) Surgery for loco-regional recurrence after nephrectomy for renal cell carcinoma (RCC): outcomes after initial incomplete resection and implantational recurrences. In: BJU INTERNATIONAL. (pp. 42 - 42). WILEY-BLACKWELL

Dudderidge, TJ; Kelly, J; Wollenschlaeger, A; Leung, H; Okoturo, O; Prevost, T; Prevost, T; ... Chromosomal Replicat Grp, ; + view all (2011) DIAGNOSIS OF BLADDER CANCER BY COMBINED DETECTION OF MINICHROMOSOME MAINTENANCE 5 PROTEIN AND NMP22 IN URINE. EUR UROL SUPPL , 10 (2) 73 - 74.

Dudderidge, TJ; Robertson, N; Lavan, L; Rashid, T; Hawizy, A; Ogden, CW; (2011) Robotic prostatectomy delivers excellent outcomes and short hospital stay. Access in the NHS should be expanded not limited due to consumable costs. In: BJU INTERNATIONAL. (pp. 34 - 35). WILEY-BLACKWELL

Duhamel, L.A.E.; (2011) The role of LKB1 in the pathogenesis of Osteosarcoma. Doctoral thesis , UCL (University College London). Green open access
file

Dunn, JM; Banks, MR; Oukrif, D; Mackenzie, GD; Thorpe, S; Rodriguez-Justo, M; Winstanley, A; ... Lovat, LB; + view all (2011) Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy. ENDOSCOPY , 43 (7) 627 - 630. 10.1055/s-0030-1256443.

Dunn, JM; Bird-Lieberman, EL; Coleman, HG; Oukrif, D; Arthur, K; Lao-Sirieix, P; Murray, L; ... NIBR Study Grp, ; + view all (2011) IMAGE CYTOMETRY DNA PLOIDY ABNORMALITIES ARE AN INDEPENDENT RISK FACTOR FOR CANCER PROGRESSION IN NON-DYSPLASTIC BARRETT'S OESOPHAGUS AND LOW GRADE DYSPLASIA: RESULTS OF THE NIBR STUDY. In: GUT. (pp. ? - ?). B M J PUBLISHING GROUP

Dunn, JM; Mackenzie, GD; Thorpe, S; Austwick, M; Mosse, CA; Oukrif, D; Rodriguez-Justo, M; ... Lovat, L; + view all (2011) A Randomised Controlled Trial of ALA V Photofrin PDT for High Grade Dysplasia in Barrett's Esophagus. In: GASTROENTEROLOGY. (pp. S215 - S216). W B SAUNDERS CO-ELSEVIER INC

Dunn, JM; Mackenzie, GD; Thorpe, S; Austwick, M; Mosse, CA; Oukrif, D; Winstanley, A; ... Lovat, LB; + view all (2011) A RANDOMISED CONTROLLED TRIAL OF ALA VERSUS PHOTOFRIN PDT FOR HIGH GRADE DYSPLASIA IN BARRETT'S OESOPHAGUS. In: GUT. (pp. A172 - A172). B M J PUBLISHING GROUP

Dunn, JM; McDonald, SA; Oukrif, D; Haidry, RJ; Butt, MA; Lovat, E; Lovat, LB; ... Novelli, MR; + view all (2011) PLK-1 IS UPREGULATED IN BARRETT'S ADENOCARCINOMA AND IS A SURROGATE MARKER OF ANEUPLOIDY. In: GUT. (pp. ? - ?). B M J PUBLISHING GROUP

E

El-Sharkawi, D; Basu, S; Qian, W; D'Sa, S; Hoskin, P; Ardeshna, K; (2011) LACTATE DEHYDROGENASE LEVELS DO NOT PREDICT RELAPSE IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA. In: ANNALS OF ONCOLOGY. (pp. 223 - 223). OXFORD UNIV PRESS

Enver, T; (2011) Gene Regulatory Networks Governing Hematopoietic Stem Cell Development and Identity. BLOOD , 118 (21) p. 1815.

Esfandiari, A; Shoaib, M; Hogarth, L; Panlilio, L; (2011) ESTABLISHING PAVLOVIAN TO INSTRUMENTAL TRANSFER (PIT) WITH INTRAVENOUS NICOTINE AND SUCROSE IN RATS. In: (Proceedings) Summer Meeting of the British-Association-for-Psychopharmacology. (pp. A44-A44). SAGE PUBLICATIONS LTD

F

Farren, TW; Liu, F; Macey, MG; Jenner, M; Prentice, A; Nathwani, A; Agrawal, SG; (2011) CD160: a novel approach to minimal residual disease (MRD) assessment in chronic lymphocytic leukaemia (CLL). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 72). WILEY-BLACKWELL

Fielding, AK; (2011) Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA , 25 (6) 1255-+. 10.1016/j.hoc.2011.09.008.

Fielding, AK; (2011) Recommendations of the European Working Group for Adult ALL. In: Gökbuget, N, (ed.) Recommendations of the European Working Group for Adult ALL.

Foley, JH; Cook, PF; Nesheim, ME; (2011) Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites. Journal of Biological Chemistry , 286 (22) pp. 19280-19286. 10.1074/jbc.M110.215061.

Forster, MD; Dedes, K; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, C; ... Molife, LR; + view all (2011) Treatment with the PARP inhibitor olaparib in a patient with PTEN-deficient endometrial cancer. Nature Reviews Clinical Oncology , 8 (5) pp. 302-306.

G

Gardiner, C; Tannetta, DS; Harrison, P; Redman, CWG; Sargent, IL; (2011) Increased levels of tissue factor activity on syncytiotrophoblast microvesicles released into the maternal circulation during pre-eclampsia. In: (pp. p. 169). WILEY-BLACKWELL

Gennarino, V; Sardiello, M; Mutarelli, M; (2011) HOCTAR database: A unique resource for microRNA target prediction. Gene

Gerlach, B; Cordier, SM; Schmukle, AC; Emmerich, CH; Rieser, E; Haas, TL; Webb, AI; ... Walczak, H; + view all (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature , 471 pp. 591-596. 10.1038/nature09816.

Gerrard, G; Mudge, K; Stewart, R; Foskett, P; Stevens, D; Khorashad, JS; Szydlo, R; ... Foroni, L; + view all (2011) Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies. AMERICAN JOURNAL OF HEMATOLOGY , 86 (3) pp. 313-315. 10.1002/ajh.21954.

Grassi, S; Borroni, R; Concardi, M; Puccio, I; Diegoli, M; Grasso, M; Ciocca, O; (2011) Indagine immunoistochimica ed ultrastrutturale delle alterazioni vasali nella pelle affetta da Porpora di Bateman. Bollettino della Società Medico Chirurgica di Pavia 10.6092/2039-1404.124.956.

Gravel, S; Henn, BM; Gutenkunst, RN; Indap, AR; Marth, GT; Clark, AG; Yu, F; ... McVean, GA; + view all (2011) Demographic history and rare allele sharing among human populations. Proceedings of the National Academy of Sciences , 108 (29) pp. 11983-11988. 10.1073/pnas.1019276108.

Green, L; De Lord, C; Clark, B; Cadet, E; Rochette, J; Thein, SL; (2011) Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload. Br J Haematol , 154 (3) 288-. 10.1111/j.1365-2141.2011.08666.x.

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 3). WILEY-BLACKWELL

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (pp. p. 3).

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of an automated thrombin generation assay which is sensitive to defects of protein C pathway. In: J THROMB HAEMOST. (pp. 154 - 154). WILEY-BLACKWELL

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The effect of total hip and knee replacement surgery and dabigatran on thrombin generation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 658.

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The impact of dabigatran on thrombin generation and other haemostatic markers after orthopaedic surgery. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 76). WILEY-BLACKWELL

H

Hackshaw, A; Roughton, M; Forsyth, S; Monson, K; Reczko, K; Sainsbury, R; Baum, M; (2011) Long-term benefits of 5 years of tamoxifen: 10 year follow up of a large randomised trial in women aged at least 50 years with early breast cancer. Journal of Clinical Oncology , 29 (13) pp. 1657-1663. (In press).

Hagerstrom, MN; Rorby, E; May, G; Tipping, A; Brown, J; Karlsson, G; Enver, T; (2011) Gata2 Is a Direct Target for Smad-Mediated TGF beta Signaling in Hematopoietic Stem/Progenitor Cells. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 580). AMER SOC HEMATOLOGY

Hall, A; Isgro, G; Morris, R; Burroughs, AK; Dhillon, AP; (2011) SIZE OF SAMPLE REQUIRED FOR DIGITAL IMAGE ANALYSIS MEASUREMENT OF LIVER COLLAGEN IN CIRRHOSIS. In: (Proceedings) 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S133-S133). ELSEVIER SCIENCE BV

Harding, J.; (2011) Small RNAs as regulators of early vertebrate development. Doctoral thesis , UCL (University College London). Green open access
file

Hart, DP; Skelton, S; Moss, DS; Sansom, CE; Gomez, K; Shepherd, AJ; (2011) Use of artificial neural networks for large scale prediction of factor VIII derived CD4 T cell epitopes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 930-931.

Hartig, N; Munoz-Alegre, M; Young, L; Rodriguez-Viciana, P; (2011) Role of R-Ras GTPases in the Wnt-Planar Cell Polarity pathway. In: (Proceedings) Annual Meeting of the American-Society-for-Cell-Biology (ASCB). AMER SOC CELL BIOLOGY

Herzog, RW; Davidoff, AM; Markusic, DM; Nathwani, AC; (2011) AAV Vector Biology in Primates: Finding the Missing Link? MOL THER , 19 (11) 1923 - 1924. 10.1038/mt.2011.218.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; Oscier, DG; ... Pocock, CFE; + view all (2011) Final response assessment of the CLL208 trial: an open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukaemia (CLL). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 21). WILEY-BLACKWELL

Holme, H; Nanduri, V; (2011) Superior vena cava obstruction: dangers of a missed diagnosis. J Paediatr Child Health , 47 (3) pp. 150-151. 10.1111/j.1440-1754.2010.01741.x.

Howie, AJ; (2011) Problems with 'focal segmental glomerulosclerosis'. Pediatr Nephrol , 26 (8) pp. 1197-1205. 10.1007/s00467-010-1701-0.

Hughes, D; (2011) Gaucher disease: hematologic and oncologic implications. Clin Adv Hematol Oncol , 9 (10) pp. 771-772.

Hughes, D; Barba-Romero, MA; Hollak, CE; Giugliani, R; Deegan, PB; (2011) DELAYED MENARCHE AND EARLY MENOPAUSE IN FEMALES WITH FABRY DISEASE. Presented at: UNSPECIFIED.

I

Ibrahim, M; Dodson, A; O'Grady, T; Parry, S; Miller, K; Doolan, C; Jasani, B; (2011) HER2 ICC Web-based interpretive scheme: a pilot study by the UK National External Quality Assessment Scheme for Immunocytochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH). VIRCHOWS ARCH , 459 S73 - S74.

Ibrahim, M; Herriott, K; Parry, S; Miller, K; (2011) Audit of breast biomarkers markers, HER2.ER & PR in the UK: an update by the UK National External Quality Assessment Scheme for Immunocytochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH). VIRCHOWS ARCH , 459 S74 - S74.

Ibrahim, M; Parry, S; Miller, K; (2011) Immunocytochemical staining of breast biomarkers HER2, ER and PR; potential pitfalls of false positive/negative staining: findings of the UK NEQAS ICC & ISH. VIRCHOWS ARCH , 459 S74 - S74.

Iorio, M; Piovan, C; Di Leva, G; Palmieri, D; Casalini, P; Braccioli, L; Tortoreto, M; ... Tagliabue, E; + view all (2011) Breast cancer and microRNAs: Therapeutic impact. BREAST , 20 S6 - S6.

Isgro, G; Hall, AR; Andreana, L; Luong, T; Burroughs, AK; Dhillon, AP; (2011) EDITED AND NON-EDITED COLLAGEN PROPORTIONATE AREA: PREDICTION OF DECOMPENSATION IN CIRRHOSIS. In: HEPATOLOGY. (pp. 1276A - 1276A). WILEY-BLACKWELL

J

JD, O; Adcock, DM; Ambrose Bush, T; de Moerloose, P; Gardiner, C; Ginyard, M; McMahan, CA; ... others, ; + view all (2011) Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Clinical and Laboratory Standards Institute

Jeyapalan, JN; Mumin, MA; Forshew, T; Lawson, ARJ; Tatevossian, RG; Jacques, TS; Sheer, D; (2011) MICRORNA EXPRESSION IN PAEDIATRIC BRAIN TUMOURS. In: NEURO-ONCOLOGY. (pp. 6 - 6). OXFORD UNIV PRESS INC

Jose Garcia-Gomez, J; Babiano, R; Lebaron, S; Froment, C; Monsarrat, B; Henry, Y; de la Cruz, J; (2011) Nop6, a component of 90S pre-ribosomal particles, is required for 40S ribosomal subunit biogenesis in Saccharomyces cerevisiae. RNA BIOLOGY , 8 (1) pp. 112-124. 10.4161/rna.8.1.14143.

K

Kallinikou, K; Anjos-Afonso, F; Blundell, MP; Ings, SJ; Kassen, D; Thrasher, AJ; Linch, DC; ... Yong, K; + view all (2011) CD26 Inhibition Can Aid the Homing of Cytokine Activated Mobilized Peripheral Blood (MPB)CD34+Cells to the Bone Marrow (BM) but a Ligand Dependent Attachment Defect Prevents Their Long Term Retention and Subsequent Engraftment. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 68). AMER SOC HEMATOLOGY

Kalson, NS; Gikas, PD; Tirabosco, R; O'Donnell, P; Skinner, JA; Flanagan, AM; (2011) Destructive synovial hemangioma of the hip resembling pigmented villonodular synovitis. J Arthroplasty , 26 (2) 339.e15-339.e20. 10.1016/j.arth.2010.02.015.

Kanga, U; McWhinnie, A; Mourya, MK; Sharma, R; Shaw, BE; Madrigal, A; Mehra, NK; (2011) HLA-DPB1 POLYMORPHISM IN NORTH INDIAN POPULATION. In: (Proceedings) 37th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. S137-S137). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, P; Yong, K; (2011) Deregulation of the bone marrow stromal compartment occurs early in multiple myeloma and precedes osteolytic bone disease. In: BONE. (pp. S253 - S254). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, PI; Yong, K; (2011) Mechanisms of osteoblast supression in multiple myeolma. In: BONE. (pp. S37 - S37). ELSEVIER SCIENCE INC

Katodritou, E; Terpos, E; North, J; Kottaridis, P; Verrou, E; Gastari, V; Chadjiaggelidou, C; ... Lowdell, MW; + view all (2011) Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells. AMERICAN JOURNAL OF HEMATOLOGY , 86 (12) pp. 967-973. 10.1002/ajh.22163.

Kautz-Neu, K; Noordegraaf, M; Dinges, S; Bennett, CL; John, D; Clausen, BE; von Stebut, E; (2011) Langerhans cells are negative regulators of the anti-leishmania response. Journal of Experimental Medicine , 208 (5) pp. 885-91. 10.1084/jem.20102318.

Knowles, S; Cohen, H; (2011) The 2010 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Kothari, J; Ljubic, A; Peggs, KS; Thomson, K; Morris, E; Virchis, AE; Lambert, J; ... Ardeshna, KM; + view all (2011) Autologous Stem Cell Transplantation Using BEAM Conditioning Is Highly Effective in Patients with Follicular Lymphoma Regardless of Prior Rituximab Exposure. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 886). AMER SOC HEMATOLOGY

Kristeleit, RS; baird, R; venugopal, B; wilkins, D; maccormick, F; granata, R; crawford, D; ... de bono, J; + view all (2011) Cardiac effects in a first-in-human (FIH), pharmacokinetic (PK), pharmacodynamic (PD) phase I trial of JNJ-26481585, a second-generation oral hydroxamate histone deacetylase inhibitor (HDACi), in patients with refractory cancer. Molecular Cancer Therapeutics , 10 (11)

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; ... GCIG, ; + view all (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. J Clin Oncol , 29 (18_suppl) LBA5006-.

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; ... GCIG, ; + view all (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. J Clin Oncol , 29 (15_suppl) LBA5006-.

Kroemer, G; Adjemian, S; Michaud, M; Martins, I; Kepp, O; Sukkurwala, AQ; Menger, L; ... Zitvogel, L; + view all (2011) [Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]. Bull Mem Acad R Med Belg , 166 (3-4) pp. 130-138.

Krug, LM; Kindler, H; Calvert, H; Manegold, C; Tsao, AS; Fennell, D; Lubiniecki, GM; ... Baas, P; + view all (2011) VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase iii, Randomized, Double-Blind, Placebo-Controlled Trial. EUROPEAN JOURNAL OF CANCER , 47 pp. 2-3. 10.1016/S0959-8049(11)70098-3.

Krzystanek, M; Eklund, AC; Birkbak, NJ; Tegze, B; Gautier, L; Blicher, LH; Swanton, C; ... Szallasi, Z; + view all (2011) PARALLEL SELECTION OF CHEMOTHERAPY-RESISTANT CELL LINES TO ILLUMINATE MECHANISMS OF DRUG RESISTANCE IN HUMAN TUMORS. In: (Proceedings) Conference on Improving Care and Knowledge through Translational Research (IMPAKT) Breast Cancer. (pp. p. 45). OXFORD UNIV PRESS

Kudsiova, L; Fridrich, B; Ho, J; Mustapa, MFM; Campbell, F; Welser, K; Keppler, M; ... Lawrence, MJ; + view all (2011) Lipopolyplex Ternary Delivery Systems Incorporating C14 Glycerol-Based Lipids. MOL PHARMACEUT , 8 (5) 1831 - 1847. 10.1021/mp2001796.

L

Lawley, S; Cohen, H; Pavord, S; Fitzmaurice, D; (2011) Dragons den on oral anticoagulants for atrial fibrillation. Presented at: British society for haematology annual scientific meeting, Brighton.

Lawrie, AS; Canciani, MT; Iseppi, J; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) High throughput detection of von Willebrand's disease using a new coagulation analyser. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 672.

Ledermann, JA; Harter, P; Gourley, C; Friedlander, M; Vergote, IB; Rustin, GJ; Scott, C; ... Matulonis, U; + view all (2011) Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). J Clin Oncol , 29 (15_suppl) 5003-.

Lee, F; Madrigal, A; Shaw, B; Saudemont, A; (2011) Study of the effect of CAMPATH on cord blood and peripheral blood cells. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 184). WILEY-BLACKWELL

Lemech, C; Arkenau, HT; (2011) Biomarkers in advanced colorectal cancer: Challenges in translating clinical research into practice. Cancers , 3 (2) pp. 1844-1860. 10.3390/cancers3021844. Gold open access

Lemech, CR; Kristeleit, RS; Arkenau, H; (2011) Novel Oncology drug development strategies in the era of personalised medicine. In: Drug Discovery and Development. InTech

Lemech, CR; Kristeleit, RS; Arkenau, HT; (2011) Novel Oncology Drug Development Strategies in the Era of Personalised Medicine. In: Kapetanovic, IM, (ed.) Drug Discovery and Development - Present and Future.

Leon, TE; (2011) Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4. Journal of Immunology 10.4049/jimmunol.1000585.

Li, S-C; Chan, W-C; Lai, C-H; Tsai, K-W; Hsu, C-N; Jou, Y-S; Chen, H-C; ... Lin, W-C; + view all (2011) UMARS: Un-MAppable Reads Solution. BMC Bioinformatics , 12 (Suppl 1) S9-S9. 10.1186/1471-2105-12-S1-S9. Gold open access

Li, S-C; Liao, Y-L; Chan, W-C; Ho, M-R; Tsai, K-W; Hu, L-Y; Lai, C-H; ... Lin, W-C; + view all (2011) Interrogation of rabbit miRNAs and their isomiRs. Genomics , 98 (6) pp. 453-459. 10.1016/j.ygeno.2011.08.008.

Lin, S; Kiakos, K; Lee, M; Hochhauser, D; Hartley, JA; (2011) Targeting the Mlul cell cycle box (MCB) sequence 5 '-ACGCGT-3 ' in the human Dbf4 promoter using the rationally designed polyamide formamido-imidazole-pyrrole-imidazole (f-IPI). CANCER RESEARCH , 71 10.1158/1538-7445.AM2011-665.

Liu, H; Wang, W; Chew, S-K; Lee, S-C; Li, J; Vassiliou, GS; Green, T; ... Liu, P; + view all (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) pp. 689-695. 10.1002/dvg.20741.

Loizou, JI; Sancho, R; Kanu, N; Bolland, DJ; Yang, F; Rada, C; Corcoran, AE; (2011) ATMIN is required for maintenance of genomic stability and suppression of B cell lymphoma. Cancer Cell , 19 (5) pp. 587-600. 10.1016/j.ccr.2011.03.022.

Lopez, MN; Pesce, B; Kurte, M; Perez, C; Segal, G; Roa, J; Aguillon, JC; ... Salazar-Onfray, F; + view all (2011) A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-beta plus tolerogenic dendritic cells. IMMUNOBIOLOGY , 216 (10) 1117 - 1126. 10.1016/j.imbio.2011.04.006.

Lotta, LA; Wu, HM; Scully, MA; Noris, M; Veyradier, A; Mackie, IJ; Remuzzi, G; ... Peyvandi, F; + view all (2011) Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 966). AMER SOC HEMATOLOGY

M

Ma, GL; Dhillon, AP; Hall, AR; Burroughs, AK; Tsochatzis, E; Burgess, G; Guo, F; (2011) ISHAK STAGE PROGRESSION RATE MODELING FOR POST LIVER TRANSPLANT (POLT) PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION. In: HEPATOLOGY. (pp. 579A - 579A). WILEY-BLACKWELL

MacGregor, A; Frith, A; Hackshaw, A; (2011) Migraine and co-morbid depression: an open label study of eletriptan and sertraline. Journal of Clinical Psychopharmacology , 31 (3) pp. 392-393. (In press).

Mackie, IJ; Chitolie, A; Westwood, JP; Lawrie, A; Carr, P; Liesner, R; Cohen, H; (2011) Antibodies against prothrombin/phosphatidyl serine in thrombosis an pregnancy morbidity. In: (Proceedings) VII European Forum on antiphospholipid antibodies.

Mackie, IJ; Langley, K; Chitolie, A; Leisner, R; Scully, M; Machin, S; Peyvandi, F; (2011) Discrepancies between different types of ADAMTS13 assays in patients with thrombotic microangiopathies. J THROMB HAEMOST , 9 210 - 210.

Mandeville, H.C.; (2011) Exploration of the clinical interaction between vascular targeting agents and radiotherapy. Doctoral thesis , UCL (University College London). Green open access
file

Maramba, A; North, J; Lowdell, MW; Donaldson, C; (2011) IgM ligation triggers Zeta associated protein of 70 kDa (ZAP-70) tyrosine 292 and 319 phosphorylation in B-Chronic lymphocytic leukaemia (B-CLL). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 72-73). WILEY-BLACKWELL

Marks, DJB; Smith, PJ; Rahman, FZ; Miller, RF; Ledermann, JA; Bloom, SL; (2011) Cryptogenic colitis due to occult cytomegalovirus infection. Frontline Gastroenterol , 2 (1) pp. 57-62. 10.1136/fg.2010.001990.

Marks, R; Rizzi, M; Neumann, C; Fielding, A; Goldacker, S; Salzer, U; Eibel, H; ... Peter, H; + view all (2011) Allogeneic stem cell transplantation in patients with common variable immunodeficiency. In: BONE MARROW TRANSPLANTATION. (pp. S163 - S163). NATURE PUBLISHING GROUP

Marsh, D.J.; (2011) The αvβ6 Integrin in cancer. Doctoral thesis , UCL (University College London). Green open access
file

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update April 2011. TISSUE ANTIGENS , 78 (4) pp. 299-306. 10.1111/j.1399-0039.2011.01758.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2011. TISSUE ANTIGENS , 78 (6) pp. 474-481. 10.1111/j.1399-0039.2011.01792.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update December 2010. TISSUE ANTIGENS , 77 (4) pp. 362-363. 10.1111/j.1399-0039.2011.01642.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2010. TISSUE ANTIGENS , 77 (2) pp. 162-166. 10.1111/j.1399-0039.2010.01594.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2011. TISSUE ANTIGENS , 78 (6) pp. 468-473. 10.1111/j.1399-0039.2011.01790.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update June 2011. TISSUE ANTIGENS , 78 (4) pp. 314-319. 10.1111/j.1399-0039.2011.01760.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update March 2011. TISSUE ANTIGENS , 78 (1) pp. 77-79. 10.1111/j.1399-0039.2011.01696.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update May 2011. TISSUE ANTIGENS , 78 (4) pp. 307-313. 10.1111/j.1399-0039.2011.01759.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update September 2010. TISSUE ANTIGENS , 77 (3) pp. 268-270. 10.1111/j.1399-0039.2010.01604.x.

Masir, N; Jones, M; Marafioti, T; Mason, DY; (2011) Heterogeneous expression of B cell-associated markers in follicular lymphoma. HISTOPATHOLOGY , 58 (4) pp. 633-636. 10.1111/j.1365-2559.2011.03782.x.

Mattes, FM; Vargas, A; Kopycinski, J; Hainsworth, EG; Sweny, P; Nebbia, G; Bazeos, A; ... Emery, VC; + view all (2011) Erratum: Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation (American Journal of Transplantation (2008) 8 (990-999) DOI: 10.1111/j.1600-6143.2008.02191.x). American Journal of Transplantation , 11 (5) 1107-. 10.1111/j.1600-6143.2011.03549.x.

Mattes, FM; Vargas, A; Kopycinski, J; Hainsworth, EG; Sweny, P; Nebbia, G; Bazeos, A; ... Klenerman, P; + view all (2011) Functional Impairment of Cytomegalovirus Specific CD8 T Cells Predicts High-Level Replication After Renal Transplantation. American Journal of Transplantation (vol 8, pg 990, 2008). WILEY-BLACKWELL

Mavroudis, C; Majumder, B; Lowdell, M; Rakhit, R; (2011) Platelet Monocyte Aggregates Correlate with Indices of Microvascular Dysfunction (Coronary Wedge Pressure and Index of Microvascular Resistance) During PCI for Stable Angina and Non-ST Segment Elevation Acute Coronary Syndrome. In: LIPPINCOTT WILLIAMS & WILKINS

Maybin, JA; Battersby, S; Hirani, N; Nikitenko, LL; Critchley, HOD; Jabbour, HN; (2011) The Expression and Regulation of Adrenomedullin in the Human Endometrium: A Candidate for Endometrial Repair. ENDOCRINOLOGY , 152 (7) pp. 2845-2856. 10.1210/en.2010-1256.

McDonald, V; Machin, SJ; Mackie, IJ; Scully, MA; (2011) The Prognostic Effects of Anti-ADAMTS13 IgG, IgA and IgM Antibody Subclasses In Acute Idiopathic TTP and the Effect of Rituximab. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1421). AMER SOC HEMATOLOGY

McDonald, V; Pizzey, A; Machin, SJ; Scully, MA; (2011) The development of acute idiopathic TTP is not associated with changes in T cell or T-regulatory cell numbers. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 915-916.

McIntosh, J; Lenting, P; Tuddenham, E; Nawathe, S; Waddington, S; Gray, J; Davidoff, A; (2011) AAV mediated Factor VIII expression from a novel expression cassette with a potent codon-optimised FVIII construct. HUMAN GENE THERAPY , 22 (10) A28 - A28.

McIntosh, JH; Cochrane, M; Cobbold, S; Waldmann, H; Nathwani, SA; Davidoff, AM; Nathwani, AC; (2011) Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine. Gene Ther. 10.1038/gt.2011.64.

Mellars, G; Gomez, K; (2011) Erratum: Mutation detection by Southern blotting (Methods in Molecular Biology 688 DOI: 10.1007/978-1-60761-947-5). (Vol.688).

Mellars, G; Gomez, K; (2011) Mutation detection by Southern blotting. Methods Mol Biol , 688 pp. 281-291. 10.1007/978-1-60761-947-5_19.

Middleton, GW; Gwyther, SJ; Brown, SR; Maughan, T; Olivier, C; Richman, S; Maisey, NR; ... UK NCRI Colorectal Clinical Studies Group, ; + view all (2011) Biomodulation of irinotecan using ciclosporin: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC). J Clin Oncol , 29 (15_suppl) 3566-.

Milojkovic, D; Apperley, JF; Ibrahim, AR; Bua, M; Reid, A; Gerrard, G; Foroni, L; ... Marin, D; + view all (2011) Prolonged Survival Following Imatinib Failure for CML Patients in CP May Require Multiple TKI Strategies for Responding Patients. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 1613-1614). AMER SOC HEMATOLOGY

Milojkovic, D; Gerrard, G; Paliompeis, C; Bua, M; Reid, A; Alikian, M; Khorashad, J; ... Apperley, JF; + view all (2011) The Natural History of RTQ-PCR Levels After the Achievement of Complete Molecular Remission (CMR): Implications for 'Stopping' Studies. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 278). AMER SOC HEMATOLOGY

Milojkovic, D; Ibrahim, AR; Foroni, L; Lucas, C; Gerrard, G; Wang, L; Szydlo, RM; ... Marin, D; + view all (2011) Assessment of BCR-ABL1 Transcript Levels At 3 Months Is the Only Requirement for Predicting Outcome for Patients with Chronic Myeloid Leukemia Treated with Imatinib. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 729). AMER SOC HEMATOLOGY

Mindell, J; Aresu, M; Zaninotto, P; Falaschetti, E; Poulter, N; (2011) Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey-2006. Clinical Endocrinology , 75 (5) 621 - 627. 10.1111/j.1365-2265.2011.04094.x. Green open access
filefile

Moore, S; Peggs, K; Thomson, K; Ljubic, A; Goldstone, AH; Linch, DC; Ardeshna, K; (2011) AUTOLOGOUS STEM CELL TRANSPLANTATION REMAINS BENEFICIAL FOR PATIENTS RELAPSING AFTER R-CHOP AND WHO RESPOND TO SALVAGE CHEMOTHERAPY. In: ANNALS OF ONCOLOGY. (pp. 107 - 107). OXFORD UNIV PRESS

P

Pansuriya, TC; Oosting, J; Verdegaal, SHM; Flanagan, AM; Sciot, R; Kindblom, L-G; Hogendoorn, PCW; ... Bovée, JVMG; + view all (2011) Maffucci syndrome: a genome-wide analysis using high resolution single nucleotide polymorphism and expression arrays on four cases. Genes Chromosomes Cancer , 50 (9) pp. 673-679. 10.1002/gcc.20889.

Patel, B; Fielding, AK; (2011) Recommendations of the European Working Group for Adult ALL. In: Gökbuget, N, (ed.) Recommendations of the European Working Group for Adult ALL.

Patel, GS; Kiuchi, T; Lawler, K; Ofo, E; Fruhwirth, GO; Kelleher, M; Shamil, E; ... Ng, T; + view all (2011) The challenges of integrating molecular imaging into the optimization of cancer therapy. Integr Biol (Camb) , 3 (6) pp. 603-631. 10.1039/c0ib00131g.

Peggs, K; (2011) The role of alemtuzumab in allogeneic stem cell transplantation. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 19). WILEY-BLACKWELL

Peggs, KS; (2011) Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignancies. EXPERT REVIEW OF ANTICANCER THERAPY , 11 (11) pp. 1667-1670. 10.1586/ERA.11.159.

Perera, G; Ainali, C; Barinaga, G; Williams, A; Mirza, M; Kassen, D; Barker, J; ... Nestle, F; + view all (2011) Systems analysis of psoriasis reveals a dominant IL-22 signature and IL-22 as non redundant checkpoint in psoriatic inflammation. In: JOURNAL OF INVESTIGATIVE DERMATOLOGY. (pp. S89 - S89). NATURE PUBLISHING GROUP

Perera, GK; Williams, A; Barinaga, G; Kassen, D; Barker, J; Ouyang, W; Nestle, FO; (2011) IL-22 is a potential therapeutic target in psoriasis. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 905 - 906). WILEY-BLACKWELL

Pillay, N; Amary, FM; Berisha, F; Tirabosco, R; Flanagan, AM; (2011) P63 does not regulate brachyury expression in human chordomas and osteosarcomas. HISTOPATHOLOGY , 59 (5) pp. 1025-1027. 10.1111/j.1365-2559.2011.03973.x.

Pillay, N; Fernanda, MF; Berisha, F; Tirabosco, R; Flanagan, AM; (2011) P63 Does Not Regulate Brachyury in Chordomas and Osteosarcomas. In: (Proceedings) 199th Scientific Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. S24-S24). WILEY-BLACKWELL

R

REA, CJ; FOLEY, JH; INGERSLEV, J; SØRENSEN, B; (2011) Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A. Journal of Thrombosis and Haemostasis , 9 (3) pp. 510-516. 10.1111/j.1538-7836.2010.04171.x.

Raj, D; Peggs, K; Pule, M; Linch, D; Davies, M; Nathwani, A; (2011) Adoptive immunotherapy for patients with chronic lymphocytic leukaemia using a chimeric antigen receptor targeting CD23. In: HUMAN GENE THERAPY. (pp. A120 - A121). MARY ANN LIEBERT INC

Rajkumar, V; Dearling, JL; Packard, A; Pedley, RB; (2011) Radioimmunotherapy: optimizing delivery to solid tumors. Ther Deliv , 2 (5) pp. 567-572.

Ran, Y; Ethaar, E-E; Vineeth, R; Mathew, R; Barbara, PR; Erik, A; (2011) One-pot Formation of a I-125-labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS , 54 S57-S57.

Rashid, TG; Smith, TB; Prasad, AK; Dudderidge, TJ; Christmas, TJ; (2011) Eponymous Anonymous: the men behind the names. In: BJU INTERNATIONAL. (pp. 65 - 65). WILEY-BLACKWELL

Richardson, S; (2011) The Hands-on Guide to Data Interpretation. In: Abraham, S and Kulkarni, K and Madhu, R and Provan, D, (eds.) The Hands-on Guide to Data Interpretation. Wiley-Blackwell

Richardson, SE; McNamara, C; (2011) The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future. Adv Hematol , 2011 865870-. 10.1155/2011/865870.

Riddell, A; Abdul-Kadir, R; Pollard, D; Tuddenham, E; Gomez, K; (2011) Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thromb.Haemost. , 106 (3) pp. 521-527.

Robinson, J; Mistry, K; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2011) The IMGT/HLA Database. Nucleic Acids Research , 39 D1171-D1176.

Rollins-Raval, MA; Fuhrer, K; Marafioti, T; Roth, CG; (2011) ALDH1, Carbonic Anhydrase 1, and CD2AP: Novel, Diagnostically Useful Immunohistochemical Markers To Identify Erythroid Precursors in Bone Marrow Biopsies. In: (Proceedings) 100th Annual Meeting of the United States and Canadian-Academy-of-Pathology. (pp. 318A-318A). NATURE PUBLISHING GROUP

S

Salazar, R; Plummer, R; Oaknin, A; Robinson, A; Pardo, B; Soto-Matos, A; Yovine, A; ... Calvert, AH; + view all (2011) Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas. INVEST NEW DRUG , 29 (6) 1406 - 1413. 10.1007/s10637-010-9488-1.

Salomoni, P; (2011) KAPping PML nuclear body number. CELL CYCLE , 10 (5) 735 - 736. 10.4161/cc.10.5.14927.

Saravanan, K; Barlow, HC; Barton, M; Calvert, AH; Golding, BT; Newell, DR; Northen, JS; ... Griffin, RJ; + view all (2011) Nucleoside Transport Inhibitors: Structure-Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of alpha(1)-Acid Glycoprotein. J MED CHEM , 54 (6) 1847 - 1859. 10.1021/jm101493z.

Serrano, AE; Menares-Castillo, E; Garrido-Tapia, M; Ribeiro, CH; Hernandez, CJ; Mendoza-Naranjo, A; Gatica-Andrades, M; ... Molina, MC; + view all (2011) Interleukin 10 decreases MICA expression on melanoma cell surface. IMMUNOL CELL BIOL , 89 (3) 447 - 457. 10.1038/icb.2010.100.

Setty, S; Reddell, A; England, A; Gomez, K; Kadir, R; (2011) The role of recombinant factor VIIa for obstetric block in women with severe factor XI deficiency. HAEMOPHILIA , 17 (6) pp. 906-909. 10.1111/j.1365-2516.2011.02525.x.

Shiltagh, N; Hansen, FD; Gomez, K; Perkins, SJ; Tuddenham, EGD; (2011) Reassignment of the modular architecture of von Willebrand factor: novel structural insights into the non-a repeat region revealing the major FVIII binding region. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 661-662.

Shimazu, S; Nagamura, Y; Yaguchi, H; Ohkura, N; Tsukada, T; (2011) Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms. Cancer Sci , 102 (11) pp. 2097-2102. 10.1111/j.1349-7006.2011.02055.x.

Simmonds, N; Bates, AW; (2011) Reporting Paneth Cell Metaplasia in Paediatric GI Biopsies: An Audit on Current Practice and Review of Guidelines. In: JOURNAL OF PATHOLOGY. (pp. S19 - S19). WILEY-BLACKWELL

Sivabalasingham, S; Fersht, N; D'Souza, D; Rosenberg, I; Stacey, C; Davies, P; Guerro-Urbano, T; (2011) Preliminary Results from a Phase I/II Study of Intensity Modulated Radiotherapy in the Treatment of Meningiomas. CLIN ONCOL-UK , 23 (3) S53 - S53.

Starke, RD; Paschalaki, KE; Ferraro, F; Dryden, NH; McKinnon, TAJ; Sutton, RE; Payne, EM; ... Randi, AM; + view all (2011) BLOOD-DERIVED ENDOTHELIAL PROGENITOR CELLS FROM VON WILLEBRAND'S DISEASE PATIENTS DEMONSTRATE THAT VON WILLEBRAND FACTOR REGULATES ANGIOGENESIS. HEART , 97 (20) 14 - 14. 10.1136/heartjnl-2011-300920b.39.

Steele, AJ; Prentice, AG; Last, V; Hoffbrand, AV; Wickremasinghe, RG; (2011) The p90RSK Inhibitor BI-D1870 Induces Apoptosis in CLL Cells. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1067). AMER SOC HEMATOLOGY

Strenger, V; Pfurtscheller, K; Wendelin, G; Aberle, SW; Nacheva, EP; Zohrer, B; Zenz, W; ... Popow-Kraupp, T; + view all (2011) Differentiating Inherited Human Herpesvirus Type 6 Genome from Primary Human Herpesvirus Type 6 Infection by Means of Dried Blood Spot from the Newborn Screening Card. J PEDIATR-US , 159 (5) 859 - 861. 10.1016/j.jpeds.2011.06.032.

Sá, MI; Nicol, ED; Stirrup, J; Crean, A; Roughton, M; Padley, SPG; Rubens, MB; (2011) Implications for single phase prospective CT coronary angiography for the diagnosis of significant coronary stenoses in clinical practice. Int J Cardiol , 147 (3) pp. 393-397. 10.1016/j.ijcard.2009.09.542.

T

Tat, PA; Sumer, H; Pralong, D; Verma, PJ; (2011) The Efficiency of Cell Fusion-Based Reprogramming Is Affected by the Somatic Cell Type and the Age of Somatic Cells. Cellular Reprogramming (Formerly "Cloning and Stem Cells") , 13 (4) pp. 331-344. 10.1089/cell.2011.0002.

Tavarozzi, F; Mayor, NP; Cooke, L; Madrigal, JA; Marsh, SGE; Shaw, BE; (2011) Impact of HLA-DPA1 matching status on outcome, following unrelated donor hematopoietic stem cell transplantation, in the context of a 10/10 HLA-matched background. In: TISSUE ANTIGENS. (pp. 381 - 381). WILEY-BLACKWELL

Tsai, K-W; Liao, Y-L; Wu, C-W; Hu, L-Y; Li, S-C; Chan, W-C; Ho, M-R; ... Lin, W-C; + view all (2011) Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics , 6 (10) pp. 1189-1197. 10.4161/epi.6.10.16535.

Tsai, K-W; Wu, C-W; Hu, L-Y; Li, S-C; Liao, Y-L; Lai, C-H; Kao, H-W; ... Lin, W-C; + view all (2011) Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. International Journal of Cancer , 129 (11) pp. 2600-2610. 10.1002/ijc.25919.

Tsochatzis, EA; Germani, G; Dhillon, AP; Burroughs, AK; (2011) Noninvasive assessment of liver fibrosis: the clinical context and question are important. Hepatology (Baltimore, Md.) , 54 (6) 2276-.

Tsochatzis, EA; Manousou, P; Fede, G; Dhillon, AP; Burroughs, AK; (2011) Validating non-invasive markers of fibrosis: the need for a new histological reference standard. GUT , 60 (10) 1442 - 1443. 10.1136/gut.2010.229484.

Tsogka, E; Brazma, D; Howard-Reeves, J; Grace, C; Nacheva, EP; (2011) MOLECULAR Karyotyping In CLL - COST Neutral Alternative to FISH SCREENING for Detection of Clinically Relevant Genome Imbalances. In: (pp. p. 1520).

Tulpule, S; Russell, NH; Byrne, J; Das-Gupta, EP; Ethell, ME; Figueroa, D; Madrigal, JA; ... Shaw, BE; + view all (2011) High Absolute T Regulatory Cell Counts and Resistance of CD8 Central Memory Cells to Killing by Fludarabine Predicts for Poor Responses to DLI in the Context of a Pre-DLI Lymphoreduction, Strategy. In: (pp. p. 834).

V

Vilella, AJ; Birney, E; Flicek, P; Herrero, J; (2011) Considerations for the inclusion of 2x mammalian genomes in phylogenetic analyses. Genome Biology , 12 , Article 401. 10.1186/gb-2011-12-2-401. Green open access

Virgilio, M; Payne, E; Narla, A; Sun, H; Paw, BH; Look, T; Ebert, BL; ... Khanna-Gupta, A; + view all (2011) L-Leucine Improves the Anemia of the 5q-Syndrome Via Activation of the mTOR (mammalian target of rapamycin) Pathway. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 443-444). AMER SOC HEMATOLOGY

Visone, R; Veronese, A; Rassenti, LZ; Balatti, V; Pearl, DK; Acunzo, M; Volinia, S; ... Croce, CM; + view all (2011) miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. BLOOD , 118 (11) 3072 - 3079. 10.1182/blood-2011-01-333484.

van der Pol, E; Gardiner, C; Harrison, P; Grootemaat, AE; Sturk, A; van Leeuwen, TG; Nieuwland, R; (2011) Size distribution and concentration of microparticles and exosomes determined by advanced optical and non-optical detection methods. In: (pp. p. 184). WILEY-BLACKWELL

W

Wan, SG; Taccioli, C; Jiang, YB; Chen, HP; Smalley, KJ; Huang, K; Liu, XP; ... Fong, LYY; + view all (2011) Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression. INT J CANCER , 129 (2) 331 - 345. 10.1002/ijc.25688.

Wechalekar, AD; Dubrey, SW; Comenzo, RL; (2011) Amyloidosis. In: Myeloma: Pathology, Diagnosis, and Treatment. (pp. 174-189).

Weinreb, N; Belmatoug, N; Bembi, B; Bodamer, O; Cappellini, MD; Deegan, PB; Elstein, D; ... Therapeutic Goals MAP Taskforce, ; + view all (2011) A novel tool for mapping disease severity and outcomes in patients with Gaucher disease utilising the therapeutic goals. In: MOLECULAR GENETICS AND METABOLISM. (pp. S46 - S46). ACADEMIC PRESS INC ELSEVIER SCIENCE

Westin, J; Hellstrand, K; Dhillon, AP; Lagging, M; DITTO-HCV Study Grp, ; (2011) Are FoxP3+cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C? J VIRAL HEPATITIS , 18 (2) 149 - 151. 10.1111/j.1365-2893.2010.01277.x.

Whelan, JS; Gelderblom, AH; Jinks, R; Sydes, M; Bramwell, VH; van Glabbeke, M; Grimer, RJ; ... Taminiau, AHM; + view all (2011) Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup randomised controlled trials. Eur J Cancer (47) pp. 895-902.

Whelan, JS; Jinks, RC; McTiernan, A; Sydes, MR; Hook, JM; Trani, L; Uscinska, B; ... Gelderblom, H; + view all (2011) Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol 10.1093/annonc/mdr491.

Whelan, JS; Miller, R; (2011) Lung carcinoma with hypertropic osteoarthropathy in a teenager. Rare Tumours , 3:e8

Whitmore, C; Ackroyd, MR; Ashraf, A; Alyoshkin, B; Muntoni, F; Brown, SC; (2011) Generation of a new mouse model for therapeutic testing in the dystroglycanopathies. In: NEUROMUSCULAR DISORDERS. (pp. 664 - 664). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Ashraf, A; Brown, SC; (2011) Deposition of the inner limiting membrane in the eye of a mouse model for Muscle Eye Brain disease. In: (Proceedings) 16th International Congress of the World-Muscle-Society. (pp. p. 665). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Ashraf, A; Brown, SC; (2011) Deposition of the inner limiting membrane in the eye of a mouse model for Muscle Eye Brain disease. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference 2011. (pp. S11-S11). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Muses, S; Ashraf, A; Muntoni, F; Brown, SC; Wells, DJ; (2011) Assessing the therapeutic potential of LARGE in a new mouse model of dystroglycanopathy. In: NEUROMUSCULAR DISORDERS. (pp. 665 - 665). PERGAMON-ELSEVIER SCIENCE LTD

Wickremasinghe, RG; Prentice, AG; Steele, AJ; (2011) p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. LEUKEMIA , 25 (9) 1400 - 1407. 10.1038/leu.2011.103.

Williams, E; Ratnaraj, D; Holme, H; (2011) IS ASSISTED REPRODUCTIVE TECHNOLOGY ASSOCIATED WITH INCREASED RISK OF CANCER? PEDIATRIC RESEARCH , 70 p. 360. 10.1038/pr.2011.585.

Wykosky, J; Fenton, T; Furnari, F; Cavenee, WK; (2011) Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations. Chin J Cancer , 30 (1) pp. 5-12. Gold open access

Y

Young, RJ; Tin, A; Brown, NJ; Staton, C; Lee, SM; Jital, M; Woll, P; (2011) SERUM BIOMARKERS IN LUNG CANCER PATIENTS FROM TWO CLINICAL TRIALS OF CHEMOTHERAPY WITH OR WITHOUT THALIDOMIDE. JOURNAL OF THORACIC ONCOLOGY , 6 (6) S1058-S1059.

Z

Zhao, Y-H; Wang, D-P; Zhang, L-L; Zhang, F; Wang, D-M; Zhang, W-Y; (2011) Genomic expression profiles of blood and placenta reveal significant immune-related pathways and categories in Chinese women with gestational diabetes mellitus. Diabetic Medicine , 28 (2) pp. 237-246. 10.1111/j.1464-5491.2010.03140.x.

This list was generated on Sun Jun 17 02:30:11 2018 BST.